The complement system in NMOSD and MG: A target for therapeutic benefit?
touchPANEL DISCUSSION for touchOPHTHALMOLOGY
Listen to a panel of leading experts discuss the evidence for complement involvement in the pathogenesis of neuromyelitis optica spectrum disorder and myasthenia gravis, review the markers of complement activation, and highlight the implications of the latest data for complement therapeutics for practice.
The experts
Prof. Said Beydoun, Keck School of Medicine of USC, Los Angeles, CA, USA
Prof. Heinz Wiendl, University Hospital Münster, Münster, Germany
Dr Pushpa Narayanaswami, Beth Israel Deaconess Medical Center, Boston, MA, USA
This touchPODCAST…
The skinny
The skinny isn't ready yet — notes appear once the transcript is processed.